Kyung Yeol Park

Title: Innovations of Kyung Yeol Park

Introduction

Kyung Yeol Park is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 3 patents. His work focuses on improving the efficiency and effectiveness of oral tablet formulations.

Latest Patents

Kyung Yeol Park's latest patents include an oral tablet composition comprising dexlansoprazole. This invention features an oral tablet composition that includes amorphous dexlansoprazole, mannitol with an average particle size of 100 to 400 micrometers, a disintegrating agent, and a lubricant. The oral tablet composition exhibits excellent hardness, a shortened disintegration time, and improved friability. Additionally, a dry direct compression method is utilized for manufacturing, enhancing production efficiency by simplifying the process.

Another significant patent involves a method for preparing hydroxypropyl methylcellulose acetate succinate (HPMCAS) grains. This method includes esterifying hydroxypropyl methylcellulose, acetic anhydride, and succinic anhydride in a reaction medium with a catalyst. The process results in a reaction solution that forms grains when introduced to water, showcasing an innovative approach to grain size distribution control.

Career Highlights

Kyung Yeol Park is currently employed at Lotte Fine Chemical Co., Ltd. His work at this company has allowed him to focus on developing advanced pharmaceutical formulations that meet industry standards.

Collaborations

He has collaborated with notable coworkers, including Sang Youb Lee and Sung Hwan Bang, contributing to the advancement of their shared projects.

Conclusion

Kyung Yeol Park's innovative contributions to pharmaceutical compositions highlight his expertise and commitment to improving oral tablet formulations. His patents reflect a dedication to enhancing production efficiency and product quality in the pharmaceutical industry.